Rising Company Profile
What is the competitive landscape for RISING
RISING has three hundred and thirty-six approved drugs.
There are three tentative approvals on RISING drugs.
Summary for Rising
| US Patents: | 0 |
| Tradenames: | 260 |
| Ingredients: | 253 |
| NDAs: | 336 |
Drugs and US Patents for Rising
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rising | ADAPALENE | adapalene | GEL;TOPICAL | 219565-001 | Jun 30, 2026 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Rising | VALACYCLOVIR HYDROCHLORIDE | valacyclovir hydrochloride | TABLET;ORAL | 079012-002 | May 24, 2010 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rising | DESOXIMETASONE | desoximetasone | CREAM;TOPICAL | 205594-001 | Jul 2, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rising | HYDROMORPHONE HYDROCHLORIDE | hydromorphone hydrochloride | INJECTABLE;INJECTION | 078261-001 | Apr 14, 2010 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rising | OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET;ORAL | 078276-001 | Oct 26, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Rising | DUTASTERIDE | dutasteride | CAPSULE;ORAL | 202530-001 | Nov 20, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Rising
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Rising | EXTINA | ketoconazole | AEROSOL, FOAM;TOPICAL | 021738-001 | Jun 12, 2007 | 7,553,835 | ⤷ Start Trial |
| Rising | ALFENTA | alfentanil hydrochloride | INJECTABLE;INJECTION | 019353-001 | Dec 29, 1986 | 4,167,574 | ⤷ Start Trial |
| Rising | OPTIVAR | azelastine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021127-001 | May 22, 2000 | 5,164,194 | ⤷ Start Trial |
| Rising | SULFAMYLON | mafenide acetate | CREAM;TOPICAL | 016763-001 | Approved Prior to Jan 1, 1982 | 3,497,599 | ⤷ Start Trial |
| Rising | EXTINA | ketoconazole | AEROSOL, FOAM;TOPICAL | 021738-001 | Jun 12, 2007 | 8,026,238 | ⤷ Start Trial |
| Rising | SUFENTA PRESERVATIVE FREE | sufentanil citrate | INJECTABLE;INJECTION | 019050-001 | May 4, 1984 | 3,998,834 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for RISING drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Ophthalmic Solution | 0.05% | ➤ Subscribe | 2006-12-13 |
| ➤ Subscribe | Foam | 2% | ➤ Subscribe | 2009-07-30 |
| ➤ Subscribe | Nasal Spray | 0.125 mg base/spray | ➤ Subscribe | 2005-11-14 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
